Aurovela 1.5/30 Tablet
Product Images NDC 65862-935
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Aurovela 1.5/30 (NDC 65862-935). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 2 (Norethindroneethinyl Fig2)
Figure 3 (Norethindroneethinyl Fig3)
Package Label-principal Display Panel (1.5 mg/30 mcg Pouch Label)
Package Label-principal Display Panel (1.5 mg/30 mcg Blister Carton)
This is a description for a medication called "norethindrone acetate and ethinyl estradiol tablets USP" that is likely used as a form of birth control due to its ability to prevent pregnancy. However, it does not offer protection against sexually transmitted diseases or other infections. The medication is taken in a 21-day regimen.*
Norethindroneethinyl Fig6
Aurovela™ 1.5/30 is an oral contraceptive used to prevent pregnancy. It contains norethindrone acetate and ethinyl estradiol tablets USP. The product is not intended to protect against HIV infection (AIDS) or other sexually transmitted diseases. The dosage is one tablet daily for 21 days as directed by a physician. The product is stored at a temperature range of 20°C to 25°C. Aurovela™ 1.5/30 is distributed by Aurobindo Pharma USA and made in India. The text also mentions the NDC number, dosage instructions, and package brochure.*
Norethindrone Chemical Structure (Norethindroneethinyl Str1)
Ethinylestradiol Chemical Structure (Norethindroneethinyl Str2)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.